Down Syndrome Regression Disorder: When a Young Adult Suddenly Loses Skills
Down syndrome regression disorder: when a young adult suddenly loses skills
A 19-year-old man with Down syndrome finished school in December. By April his mother noticed he had stopped joining in at dinner. By June he was no longer speaking in sentences. By September he had stopped speaking at all, was incontinent after fifteen years of being fully toilet trained, and would stand in the hallway for ten minutes at a time without moving. He had lost almost every skill he had.
He was assessed for early-onset dementia. He was referred for behaviour support. Somebody suggested a psychotic depression. At one point a provider wrote in a progress note that he was “refusing to participate.”
What he had is now called Down syndrome regression disorder, and it has an international consensus definition, a diagnostic process, and treatments that work for a substantial number of people. It is also almost completely unknown in Australian disability services, which means the window in which a response is most useful tends to close while everybody argues about whether it is behaviour.
This guide is written for families, support coordinators and providers who are watching a young adult with Down syndrome lose skills and do not know what they are looking at.
What DSRD is
Down syndrome regression disorder — DSRD — is a syndrome in which a person with Down syndrome, usually an adolescent or young adult, undergoes a marked and relatively rapid loss of previously held skills.
It has gone under many names in the literature: Down syndrome disintegrative disorder, young adult regression in Down syndrome, catatonia in Down syndrome, unexplained regression in Down syndrome. The consensus term, established by an international expert group led by Santoro and colleagues in 2022, is Down syndrome regression disorder.
The essential features, as set out in a Down Syndrome WA plenary presentation on DSRD that summarises the consensus work:
Onset is typically between 10 and 30 years of age, usually after puberty.
Functional decline is rapid — a loss of daily living skills over roughly six months, often with significant loss of speech.
Cognitive decline is perceived by the people around the person.
Behaviour and mood change without obvious explanation: reduced interest in social activity, changes in eating, drinking and sleep.
Motor and catatonic features appear: slowness, freezing, difficulty initiating movement, repetitive motor loops, odd movements, mutism, posturing, stupor.
Other features may include new or increased self-talk, and depression, psychosis or frank catatonia.
And critically: DSRD is a diagnosis of exclusion. Other medical, environmental and psychiatric causes must be ruled out first — although, importantly, they can also coexist with it. That nuance gets lost. The presence of depression does not rule out DSRD; the presence of hypothyroidism does not rule out DSRD. Both might be contributing and both need treating.
What it is not
It is not dementia. Dementia in Down syndrome is uncommon before 40 and the Global Down Syndrome Foundation guidelines specifically caution against diagnosing Alzheimer’s-type dementia in adults under 40. The age profiles barely overlap: DSRD peaks in the teens and twenties, Alzheimer’s climbs from the mid-forties. Dementia also progresses gradually over years; DSRD declines over months. The distinction matters enormously because dementia has no disease-modifying treatment and DSRD often responds. We cover the dementia picture in Alzheimer’s disease and Down syndrome.
It is not autism. This confusion happens because the surface features — social withdrawal, loss of speech, repetitive movements, resistance to change — overlap. The distinction is developmental timing. Autism features must be present early in development. Autism does not appear acutely in adolescence or adulthood. A 17-year-old who was socially engaged and conversational at 15 and is now mute and withdrawn has not become autistic.
It is not behaviour. A person who stands frozen in a hallway is not refusing. A person who has stopped speaking is not being non-compliant. The catatonic features of DSRD are motor symptoms, and treating them as choices is both wrong and cruel. Of all the misreadings, this is the one that does the most damage, partly because it generates behaviour support plans that put demands on someone who is physically unable to meet them.
How common is it
Honestly: nobody knows.
The published prevalence figures are not reliable. The condition has only had a consensus definition since 2022, recognition is patchy, the case series are small, and there is no population-based study. The DSRD literature is built mostly on case reports and clinic cohorts, and the clinics that see DSRD are specialist centres in a handful of countries.
What can be said is that it is common enough that most clinicians working substantially with adolescents and young adults with Down syndrome have seen it, and rare enough that most Australian GPs, paediatricians and psychiatrists have not. That combination is the worst possible one for a family trying to get a diagnosis, because the people they can access do not recognise it and the people who recognise it are hard to access.
What triggers it
Psychosocial stress appears to be involved in a substantial proportion of cases, and the triggers identified in the consensus work and clinical experience are specific and depressingly ordinary:
- bullying
- trauma
- grief and loss
- abuse
- physical illness
- and transitions — the end of school, siblings leaving home, moving to adult services
That last cluster deserves attention from anybody working in Australian disability services, because we build those transitions and we build them badly.
Think about what happens to a young person with Down syndrome in Australia at 18 or 19. School ends — and school was the structure, the peer group, the daily routine and the social identity. The friends disperse. The familiar teachers and aides are gone overnight. Siblings have left for university or work. The paediatrician hands over to a GP. The NDIS early childhood and school-leaver pathways end and a different funding structure begins. Day program replaces school, often with older people and a different culture. And all of this happens within a few months, usually with no transition support beyond a plan review.
If you set out to design a psychosocial stressor for a young person with intellectual disability, you would struggle to improve on it.
We are not claiming the end of school causes DSRD — the mechanism is almost certainly biological and immune or inflammatory processes are under active investigation. But the association between major transition and onset is clear enough in the clinical literature that it should change how we handle school-leaver transitions, and at a minimum it should mean that somebody is actively watching a young person with Down syndrome in the eighteen months after they leave school.
Getting a diagnosis in Australia
This is harder than it should be, and the process has a shape worth knowing.
What the workup involves
The consensus diagnostic process, per the Santoro et al. framework:
A detailed developmental history establishing what the person could do before. This is where a documented baseline becomes invaluable, and it is why we push families and providers so hard on recording function in writing by the mid-thirties — in DSRD it matters by the mid-teens.
A structured questionnaire completed by the people who support the person.
Home videos of eating, walking, speech and getting stuck — including, crucially, footage from before the regression. Old phone videos, birthday party clips, school concert recordings. Find them. They are diagnostic evidence.
Investigations: brain MRI, EEG, blood tests including thyroid function, coeliac serology and autoimmune encephalitis panels, and lumbar puncture for cerebrospinal fluid studies.
In many cases those investigations come back largely normal, and that is expected rather than reassuring. In one well-documented Australian case the only abnormality found across serum antibodies, CSF, EEG, MRI and PET was mildly positive thyroglobulin antibodies with normal thyroid function. The diagnosis was still “probable DSRD.”
Who to see
There is no DSRD clinic in Australia, and that is the central problem.
The realistic pathway is a referral to a neurologist or a psychiatrist with intellectual disability experience, ideally through a specialist intellectual disability health service where one exists in your state. NSW, Victoria and Queensland have developed services of varying coverage. Children’s hospitals will see people up to young adulthood and some will continue beyond.
What helps a referral land:
Name the condition in the referral. “Query Down syndrome regression disorder, per Santoro et al. 2022 international consensus criteria” tells the receiving clinician what you are asking about and that there is a literature. A referral saying “behavioural deterioration” will be triaged differently.
Bring the before-and-after videos to the first appointment, on a device that works.
Bring a written timeline with dates: when she stopped X, when he last did Y. Months matter for distinguishing DSRD from dementia.
Bring the baseline documentation if it exists.
Ask directly whether catatonia has been assessed, and whether the Bush-Francis Catatonia Rating Scale has been applied. Catatonia is treatable and specifically treatable, and if nobody has looked for it, nobody will find it.
What gets in the way
Three things, consistently.
Diagnostic overshadowing. The symptoms get attributed to the Down syndrome. “People with Down syndrome plateau.” They do not lose speech and continence over six months.
The behaviour pathway. Once a person is in the behaviour support system, the framing is set and it is hard to escape. If you are a support coordinator and you are being asked to refer for behaviour support for a young adult with Down syndrome who has rapidly lost skills, the right response is to refer medically first and to say so in writing.
Waiting lists. Neurology and psychiatry waits in the Australian public system are long. If the decline is rapid, the emergency department is a legitimate route — a young adult with new catatonia, mutism and incontinence is an acute presentation, not a social problem, and should be treated as one.
Treatment, and what it achieves
The evidence base is case reports and case series, not trials. The consensus work is explicit that the evidence is insufficient to rank the options definitively. What follows is the current clinical picture.
Benzodiazepines
Lorazepam is first-line where catatonia is present. This is standard catatonia treatment and it is the usual starting point.
The doses are higher than people expect. Average doses in the larger DSRD series are around 5 mg a day, with a range of roughly 2 to 20 mg. Clinicians experienced with DSRD report most of their patients settling at 3 to 6 mg a day. A GP or psychiatrist unfamiliar with catatonia may start at 0.5 mg and stop there, conclude it did not work, and move on. Under-dosing is one of the commonest reasons benzodiazepines are judged to have failed.
Response varies. In the published Australian case we referenced above, oral lorazepam up to 9 mg daily combined with fluoxetine produced negligible change after two months — which is a real outcome and worth knowing, because families should not be told lorazepam always works.
Immunotherapy
Intravenous immunoglobulin (IVIg), sometimes with corticosteroids, is used on the hypothesis that an immune or inflammatory process underlies the regression. The evidence is case reports and case series, and the consensus position is that it is a possible option but the evidence is not sufficient to rank it against lorazepam or ECT.
Real outcomes vary a lot. In the Australian case, IVIg at 1 g/kg four-weekly with dexamethasone produced a small, fluctuating improvement that was not sustained beyond about three months — parent-rated functioning rose to about 55% of premorbid level, then fell back to 30% — and was ceased for lack of clear sustained benefit. Other published cases report substantial and durable responses.
Electroconvulsive therapy
ECT is reserved for severe cases that have not responded to other treatments, and it is considered effective for recovery but not for preventing relapse.
It is also, in some cases, dramatically effective. In the Australian case, right unilateral ECT produced a rapid and marked response: parent-rated functioning reached 85% of premorbid level, catatonia subsided, and the response was sustained for more than six months with maintenance ECT. Brief episodes returned after ECT was stopped and resolved with a second course of twelve treatments. The treating clinicians suggested ECT could reasonably be considered earlier where catatonia is prominent.
We are aware that ECT carries heavy cultural baggage, and that proposing it for a young person with intellectual disability raises legitimate concerns about consent and coercion. Those concerns are real and ECT in people with impaired decision-making capacity is regulated differently in each Australian state, usually requiring tribunal authorisation. But a family being offered ECT for a young adult with severe DSRD is being offered the treatment with the best-documented response rate for catatonic presentations, not a historical cruelty. The question to ask the treating team is what the alternative plan is, and over what timeframe.
Treating the coexisting things
Because DSRD can coexist with other conditions, the parallel work matters: correct hypothyroidism, treat depression, treat obstructive sleep apnoea, treat pain and constipation, address the psychosocial trigger if one is identifiable. None of these are substitutes for treating DSRD and all of them remove load.
What providers should do while this is happening
Practical, for the people actually on shift.
Stop the demands. A person with catatonic features cannot comply with prompting and pressure makes it worse. Reduce the day to essentials, slow everything down, allow very long response times. If a person takes two minutes to initiate a movement, wait two minutes.
Do not write it up as behaviour. Shift notes become medical evidence. Describe what you see: “stood at the bathroom door for 8 minutes without moving, did not respond to verbal prompt, moved when gently guided.” Not “refused to shower.”
Record video, with consent. It is the single most useful thing a provider can contribute to the diagnostic process.
Record function daily against a short list. Did she speak? How many words? Did she feed herself? Did she walk unaided? Continence? This is the data that shows response to treatment, and in DSRD improvement is often gradual — around 10% of premorbid function per month in the early phase of a successful treatment in the documented case. Without a daily record, nobody can tell whether treatment is working.
Expect the support requirement to escalate fast. A young adult who was on drop-in support may need continuous supervision within months, including overnight. That is a plan change and it is urgent — a request for an unscheduled plan reassessment on the grounds of significant change in circumstances is the right mechanism, with the medical documentation attached.
Keep the relationships going. Familiar people, familiar voices, familiar routines, no new staff if it can possibly be avoided. The person is still in there.
Protect against the secondary harms. Immobility brings pressure injuries, contractures, constipation, aspiration risk, weight loss and deep vein thrombosis. A person who is barely moving needs nursing eyes on them. Registered nursing sits at $128.05 per hour under the 2026–27 price limits, and this is exactly what it is for.
Why this guide exists
Because the gap between what the literature knows and what Australian disability services do is enormous, and because the cost of that gap falls on people in their teens and twenties at exactly the point where their adult lives were supposed to start.
A young adult with Down syndrome who loses speech and skills over six months has a medical condition with a name, a consensus definition, a diagnostic pathway and treatments with documented responses up to 85% of premorbid function. What they very often get instead is a behaviour support plan and a progress note describing them as refusing to participate.
If you are reading this because you are watching it happen: it is not behaviour, it is probably not dementia, and it may well be treatable. Ask for a neurology or intellectual disability psychiatry referral, name DSRD and the 2022 consensus criteria in the referral, ask whether catatonia has been assessed, and find the old videos.
Down Syndrome Regression Disorder: When a Young Adult Suddenly Loses Skills: common questions
A syndrome in which a person with Down syndrome, usually an adolescent or young adult, rapidly loses previously held skills — daily living skills, speech, cognition — over roughly six months, often with catatonic features such as slowness, freezing, mutism, posturing and difficulty initiating movement. The international consensus term and diagnostic framework were established by Santoro and colleagues in 2022. It is a diagnosis of exclusion, meaning other causes must be ruled out, though they can also coexist with it.
Typically between 10 and 30 years, usually after puberty. This is a very different age profile from Alzheimer’s disease in Down syndrome, which is uncommon before 40 and rises through the late forties and fifties. The age at onset is one of the most useful pieces of information in distinguishing the two.
Age and speed. DSRD peaks in the teens and twenties; dementia in Down syndrome is uncommon before 40. DSRD declines over months; dementia progresses over years. And DSRD often responds to treatment, while Alzheimer’s disease currently has no disease-modifying therapy. The Global Down Syndrome Foundation guidelines specifically caution against diagnosing Alzheimer’s-type dementia in adults with Down syndrome under 40.
No. Autism features must be present early in development; autism does not appear acutely in adolescence or adulthood. The surface overlap — withdrawal, loss of speech, repetitive movements, resistance to change — is real, which is why the distinction gets made on developmental timing rather than on the symptoms themselves.
Psychosocial stress appears to be involved in many cases. The triggers identified include bullying, trauma, grief and loss, abuse, physical illness, and major transitions — the end of school, siblings leaving home, moving from paediatric to adult services. The underlying mechanism is thought to be biological, with immune and inflammatory processes under investigation, but the association with transition is strong enough to warrant actively monitoring young people with Down syndrome in the eighteen months after they leave school.
A detailed developmental history, a structured questionnaire for support people, home videos of eating, walking and speech including footage from before the regression, brain MRI, EEG, blood tests including thyroid, coeliac and autoimmune encephalitis panels, and a lumbar puncture. Results are frequently largely normal, which is expected rather than reassuring — the diagnosis rests on the clinical picture and documented change from baseline.
Often, though the evidence base is case series rather than trials. Lorazepam is first-line where catatonia is present, at doses averaging around 5 mg a day with a range of 2 to 20 mg — under-dosing is a common reason it is wrongly judged to have failed. Immunotherapy with IVIg is used with variable results. ECT is reserved for severe non-responsive cases and has produced the most striking documented responses, including recovery to 85% of premorbid function in one well-reported case, although it is better at achieving recovery than preventing relapse.
Because catatonia treatment uses doses well above those used for anxiety. Published DSRD series average around 5 mg a day, with experienced clinicians reporting most patients at 3 to 6 mg. A clinician unfamiliar with catatonia may start at 0.5 mg, see no effect, and conclude the drug does not work. If a benzodiazepine trial is being described as unsuccessful, it is reasonable to ask what dose was reached and over what period.
There is no dedicated DSRD clinic here. The realistic route is a referral to a neurologist or a psychiatrist with intellectual disability experience, ideally through a specialist intellectual disability health service. Name DSRD and the Santoro 2022 consensus criteria explicitly in the referral, attach a dated timeline of what skills were lost when, and bring before-and-after videos. If the decline is rapid, an emergency department presentation is legitimate — new catatonia, mutism and incontinence in a young adult is acute.
Observations, not interpretations. “Stood at the bathroom door for 8 minutes without moving, did not respond to verbal prompts, moved when gently guided” is useful medical evidence. “Refused to shower” is not, and it actively pushes the case toward a behaviour pathway. Also keep a short daily functional record — words spoken, self-feeding, walking unaided, continence — because in DSRD improvement is gradual and nobody can tell whether treatment is working without it.
1300 271 824
